The UA Campus Repository is experiencing systematic automated, high-volume traffic (bots). Temporary mitigation measures to address bot traffic have been put in place; however, this has resulted in restrictions on searching WITHIN collections or using sidebar filters WITHIN collections. You can still Browse by Title/Author/Year WITHIN collections. Also, you can still search at the top level of the repository (use the search box at the top of every page) and apply filters from that search level. Export of search results has also been restricted at this time. Please contact us at any time for assistance - email repository@u.library.arizona.edu.

Show simple item record

dc.contributor.authorCentuori, Sara M.
dc.contributor.authorGomes, Cecil J.
dc.contributor.authorKim, Samuel S.
dc.contributor.authorPutnam, Charles W.
dc.contributor.authorLarsen, Brandon T.
dc.contributor.authorGarland, Linda L.
dc.contributor.authorMount, David W.
dc.contributor.authorMartinez, Jesse D.
dc.date.accessioned2018-04-02T18:43:57Z
dc.date.available2018-04-02T18:43:57Z
dc.date.issued2018-02-15
dc.identifier.citationDouble-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations 2018, 16 (1) Journal of Translational Medicineen
dc.identifier.issn1479-5876
dc.identifier.pmid29448960
dc.identifier.doi10.1186/s12967-018-1404-z
dc.identifier.urihttp://hdl.handle.net/10150/627195
dc.description.abstractBackground: The presence of B cells in early stage non-small cell lung cancer (NSCLC) is associated with longer survival, however, the role these cells play in the generation and maintenance of anti-tumor immunity is unclear. B cells differentiate into a variety of subsets with differing characteristics and functions. To date, there is limited information on the specific B cell subsets found within NSCLC. To better understand the composition of the B cell populations found in NSCLC we have begun characterizing B cells in lung tumors and have detected a population of B cells that are CD79A(+)CD27(-)IgD(-). These CD27(-)IgD(-)(double-negative) B cells have previously been characterized as unconventional memory B cells and have been detected in some autoimmune diseases and in the elderly population but have not been detected previously in tumor tissue. Methods: A total of 15 fresh untreated NSCLC tumors and 15 matched adjacent lung control tissues were dissociated and analyzed by intracellular flow cytometry to detect the B cell-related markers CD79A, CD27 and IgD. All CD79A(+) B cells subsets were classified as either naive (CD27(-)IgD(+)), affinity-matured (CD27(+)IgD(-)), early memory/germinal center cells (CD27(+)IgD(+)) or double-negative B cells (CD27(-)IgD(-)). Association of double-negative B cells with clinical data including gender, age, smoking status, tumor diagnosis and pathologic differentiation status were also examined using the logistic regression analysis for age and student's t-test for all other variables. Associations with other B cell subpopulations were examined using Spearman's rank correlation. Results: We observed that double-negative B cells were frequently abundant in lung tumors compared to normal adjacent controls (13 out of 15 cases), and in some cases made up a substantial proportion of the total B cell compartment. The presence of double-negative cells was also found to be inversely related to the presence of affinity-matured B cells within the tumor, Spearman's coefficient of -0.76. Conclusions: This study is the first to observe the presence of CD27(-)IgD(-)double-negative B cells in human NSCLC and that this population is inversely correlated with traditional affinity-matured B cell populations.
dc.description.sponsorshipNational Cancer Institute [R01 CA129688, R01 CA129688-03S1, T32 CA09213, P30CA023074]; Geographic Management of Cancer Health Disparities Program (GMaP) Region 3, an initiative of the National Cancer Institute's Center to Reduce Cancer Health Disparitiesen
dc.language.isoenen
dc.publisherBIOMED CENTRAL LTDen
dc.relation.urlhttps://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1404-zen
dc.rights© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectTIL-Bsen
dc.subjectB cellsen
dc.subjectCD27en
dc.subjectNSCLCen
dc.subjectDouble-negative B cellsen
dc.subjectLung canceren
dc.subjectMemory B cellsen
dc.titleDouble-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populationsen
dc.typeArticleen
dc.contributor.departmentUniv Arizona, Canc Ctren
dc.contributor.departmentUniv Arizona, Canc Biol Grad Interdisciplinary Programen
dc.contributor.departmentUniv Arizona, Dept Surgen
dc.contributor.departmentUniv Arizona, Dept Med, Div Hematol Oncolen
dc.contributor.departmentUniv Arizona, Dept Mol & Cellular Biolen
dc.contributor.departmentUniv Arizona, Cell & Mol Meden
dc.identifier.journalJournal of Translational Medicineen
dc.description.noteOpen access journal.en
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2018-08-18T09:26:55Z
html.description.abstractBackground: The presence of B cells in early stage non-small cell lung cancer (NSCLC) is associated with longer survival, however, the role these cells play in the generation and maintenance of anti-tumor immunity is unclear. B cells differentiate into a variety of subsets with differing characteristics and functions. To date, there is limited information on the specific B cell subsets found within NSCLC. To better understand the composition of the B cell populations found in NSCLC we have begun characterizing B cells in lung tumors and have detected a population of B cells that are CD79A(+)CD27(-)IgD(-). These CD27(-)IgD(-)(double-negative) B cells have previously been characterized as unconventional memory B cells and have been detected in some autoimmune diseases and in the elderly population but have not been detected previously in tumor tissue. Methods: A total of 15 fresh untreated NSCLC tumors and 15 matched adjacent lung control tissues were dissociated and analyzed by intracellular flow cytometry to detect the B cell-related markers CD79A, CD27 and IgD. All CD79A(+) B cells subsets were classified as either naive (CD27(-)IgD(+)), affinity-matured (CD27(+)IgD(-)), early memory/germinal center cells (CD27(+)IgD(+)) or double-negative B cells (CD27(-)IgD(-)). Association of double-negative B cells with clinical data including gender, age, smoking status, tumor diagnosis and pathologic differentiation status were also examined using the logistic regression analysis for age and student's t-test for all other variables. Associations with other B cell subpopulations were examined using Spearman's rank correlation. Results: We observed that double-negative B cells were frequently abundant in lung tumors compared to normal adjacent controls (13 out of 15 cases), and in some cases made up a substantial proportion of the total B cell compartment. The presence of double-negative cells was also found to be inversely related to the presence of affinity-matured B cells within the tumor, Spearman's coefficient of -0.76. Conclusions: This study is the first to observe the presence of CD27(-)IgD(-)double-negative B cells in human NSCLC and that this population is inversely correlated with traditional affinity-matured B cell populations.


Files in this item

Thumbnail
Name:
s12967-018-1404-z.pdf
Size:
1.041Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.